Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...

Pfizer PFE is due to report second-quarter results on Aug. 5. All eyes will be on sales of Pfizer’s oncology drugs, which ...

Moody's Corp. (NYSE: MCO) reported strong Q2 earnings with a 4% Y/Y increase in revenue and beat profit forecasts. The ...

BMO analyst John McNulty noted "significant weakness across its end-markets resulting in soft pricing" and lower volumes and ...

Hasbro (NASDAQ: HAS) shares surged on strong Q2 earnings beat and raised outlook. Its Wizards of the Coast and Digital Gaming ...

Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

Dow jumps 240 points after Trump-Japan deal; retail traders fuel meme stock gains while Tesla and Alphabet earnings loom on the trading radar.

PennyMac Financial (PFSI) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $2.67 per share a year ago. These ...

Merck recently declared a Q4 dividend of $0.81 per share while also securing Health Canada's nod for KEYTRUDA® in cervical ...

Intuitive Surgical Inc. hit a trading volume crescendo on July 22, 2025, with a stunning $1.217 billion in shares swapped, a ...